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Neonatal hyperbilirubinemia is observed during the 1st week of life in approximately 60% of the healthy infants [1]. Rising bilirubin levels in neonates 
usually reach the maximum between 72 and 120 h of life, 
and there is an increased rate of readmission before 6 days 
of life for hyperbilirubinemia [2]. American Academy of 
Pediatrics guidelines stress the need for routine pre-discharge 
measurement of bilirubin levels. With increasing demand for a 
shorter length of hospital stay for babies after delivery, there is 
an increased risk of unrecognized or delayed hyperbilirubinemia 
resulting in an increase in the incidence of babies affected with 
kernicterus [3]. The conventional method of measuring serum 
bilirubin requires repeated blood sampling which not only 
causes undue pain to the babies but also emotional stress to 
the parents [4]. Over the past three decades, transcutaneous 
bilirubinometry has emerged as a safe, simple, cost-effective 
non-invasive modality in the screening and monitoring of 
jaundiced newborns [5,6].
Several published studies reveal that there is a correlation 
between transcutaneous bilirubin (TCB) and total serum bilirubin 
(TSB) over the first few days of life. We planned this study to 
assess the correlation between TCB and TSB between 24 and 
96 h of age and also to see if skin color had any effect on TCB 
measurements.
MATERIALS AND METHODS
This was a prospective observational study conducted on unborn 
babies more than 34 weeks gestational age, from November 2014 to 
June 2016 in a neonatal unit of a medical college hospital in South 
India. The exclusion criteria were babies with established direct 
hyperbilirubinemia, neonatal septicemia, and major congenital/
gastrointestinal malformations and those started on phototherapy. 
The study protocol was approved by the Institutional Review 
Board and Ethics Committee. Written informed consent was 
obtained from the mothers for using their baby’s de-identified 
data. Confidentiality was maintained throughout the study.
Sample size was calculated using the formula: n=4 pq/(d)2 
where p=sensitivity (80%); q=1-p (20%), and d=p x absolute 
precision. This was done for an anticipated sensitivity of 80% with 
absolute precision 5% and 0.05 level of significance considering 
the incidence of hyperbilirubinemia to be 20% and lost to 
follow-up as 5%. This gave a sample size of 400. After applying 
inclusion and exclusion criteria, neonates were recruited in the 
study. The clinical and demographic profile of the mother and the 
baby was collected using a proforma. At 24 h, the babies were 
assigned a color code based on Fitzpatrick skin tone scale [7]. 
The color chart was made on a transparent sheet with each color 
code separated by half an inch width and the color codes assigned 
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for each baby were given by the principal investigating officer to 
avoid the chances of investigator bias.
Transcutaneous bilirubin levels (TCB) were estimated with 
Drager Jaundice Meter JM-105 by placing the instrument on 
the baby’s sternum. Sternum was taken as the principal site of 
measurement as several studies have shown excellent correlation 
with TSB compared to the other sites [8,9]. All measurements 
were performed with the same device according to the standard 
described technique. An average of three readings was taken as 
the TCB value. The probe was cleaned with sterile gauze before 
using for the next baby.
Approximately 1 ml of venous blood was collected in a 
Microtainer clot activator tube for assessing TSB level under 
strict aseptic precautions after the mother was explained about 
the procedure. Special care was taken to avoid exposure of the 
collected samples to light. The blood samples were taken to 
the hospital laboratory within an hour to prevent degradation 
and processed. Serum bilirubin measurements were measured 
using the Diazo method (modified Jendrassik--Grof method) 
in the automated analyzer (Cobas Integra 400 plus from Roche 
Diagnostics). Although high-performance liquid chromatography 
(HPLC) estimation is considered the gold standard, “delta 
bilirubin” or “bilirubin-albumin,” is measured by the diazo 
but not by the HPLC method as it is impractical for routine 
clinical laboratory use as it is too elaborate, time-consuming 
and expensive [10]. The maximum interval of time between the 
transcutaneous measurement and the collection of blood for TSB 
was 30 min.
All babies were visually examined every 6 h on the 1st day 
of life by a trained physician and twice a day thereafter. At 24 h, 
TSB and TCB were done on all babies and later repeated as per 
attending clinician’s discretion. Data were entered in Microsoft 
Excel and analyzed using the SPSS version 20.0 for Windows 
software. Pearson’s correlation and Bland Altman analysis were 
used for studying the data.
RESULTS
A total of 396 babies were recruited after applying the eligibility 
criteria. Demography of the cohort is given in Table 1. The 
mean TSB of the entire cohort at 24 h was 6.2±1.4 mg/dl and 
simultaneous mean TCB value was 7.7±1.4 mg/dl. Mean TCB 
was found to be uniformly higher than TSB for all variables such 
as sex, birth weight, gestational age, and growth of the baby 
(Table 1). However, among all variables, there was an excellent 
correlation between TCB and TSB (r=0.698-0.932).
In our study, most of the babies belonged to the Fitzpatrick 
skin color codes 3 and 4 with 299 babies (75.5%) in color code 
3 and 95 babies (24%) in color code 4 (Fig. 1). TCB correlates 
better in light skin tone babies (color code 3) than dark skin tone 
babies (color code 4) with r=0.874 and r=0.856, respectively. 
A total of 662 paired TCB and serum bilirubin readings were 
done in the study. Of these, 396 were done at 24 h of age. At 
48, 72, and 96 h there were 196, 48, and 22 paired readings, 
respectively.
There was a statistically significant positive correlation 
between TSB and TCBI at 24, 48, 72, and 96 h (p<0.001) 
(Table 2). As the time progresses, the correlation improves with 
maximum correlation at 96 h (r=0.981). The Bland Altman plots 
for the same time intervals were also done which showed that 
as the time progresses, the TCB overestimates TSB by a lesser 
value compared to the earlier ones. TCB overestimates TSB by an 
average of 1.5 mg/dl, 1.3 mg/dl, 0.9 mg/dl, and 0.8 mg/dl at 24, 
48, 72, and 96 h, respectively (Table 3, Figs. 2-5).
Table 1: Demography of the study population





Male 222 (56.1) 5.8 (1.1) 7.4 (1.2)
Female 174 (43.9) 5.9 (1.1s) 7.4 (1.2)
Birth weight
<2000 g 9 (2.3) 5.5 (1.0) 6.8 (0.9)
2000-2499 g 31 (7.8) 6.1 (0.9) 7.8 (1.0)
2500-2999 g 150 (37.9) 5.8 (1.0) 7.4 (1.2)
3000 g-3499 g 165 (41.7) 5.9 (1.1) 7.4 (1.2)




255 (64.4) 5.9 (1.1) 7.4 (1.2)
Instrumental delivery 19 (4.8) 6.2 (0.9) 7.7 (0.9)
Cesarean delivery 122 (30.8) 5.8 (1.2) 7.3 (1.2)
Gestational age (weeks)
34-366 28 (7.1) 5.6 (0.9) 7.2 (1.1)
37-396 313 (79) 5.8 (1.1) 7.4 (1.2)
>40 55 (13.9) 6.2 (1.2) 7.8 (1.1)
Growth
Small for gestational 
age
46 (11.6) 5.9 (0.9) 7.5 (1.1)
Approximate for 
gestational age
348 (87.9) 5.9 (1.2) 7.4 (1.2)
Large for gestational 
age
2 (0.5) 6.2 (1.1) 7.5 ( 1.3)
TSB: Total serum bilirubin, SD: Standard deviation
Figure 1: Babies were coded based on Fitzpatrick’s skin color codes 
(a) skin color code 3 (b) skin color code 4
ba
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DISCUSSION
The accuracy of transcutaneous bilirubinometry has evolved over 
the years. The older versions were considered less reliable as they 
were influenced by skin color, gestational age, birth weight, and 
other factors [11,12]. The more recent devices are based on micro 
spectrometry, and studies have shown better correlations with 
serum bilirubin levels. In our study, there was a good correlation 
between mean TCB and serum bilirubin values at 24 h with 
variables such as sex, birth weight, gestational age, and growth 
of the baby.
There have been studies to show that there is a good 
correlation in transcutaneous bilirubin levels and capillary and 
arterial bilirubin levels (r=0.7) [13]. In our study, venous samples 
were taken and compared with transcutaneous values. The serum 
bilirubin levels were measured by diazo method in our study. 
HPLC, though expensive, is the best bilirubin estimate. There 
are studies showing HPLC measured bilirubin levels showed 
good correlation at the forehead and sternum though TCB 
– forehead tend to underestimate and TCB – sternum tends to 
overestimate [14,15].
The effect of postnatal age on transcutaneous bilirubinometry 
values has not been fully explored. In 1993, Knudsen et al. 
conducted a study in all the neonatal intensive care unit babies 
and found that in multiple linear regression analysis, gestational 
age, and postnatal age showed a negative but significant 
correlation. Most of the effects were explained with the increased 
maturity and thickness of skin and changes in the amount of 
albumin-bilirubin binding. The difference was most obvious 
in preterm babies [16]. In 2000, a study of 95 newborn babies 
found no significant effect of postnatal age on Bilicheck accuracy 
when it was compared with HPLC bilirubin values (r 0.16; t-test 
for non-zero slope, t 1.53; p 0.05) [17]. Ebbesen et al. studied 
261 jaundiced infants with gestational age of 25-43 weeks and 
found that as the postnatal age increased, the TCB values were 
lower than serum bilirubin values [18]. In our study, there was 
a significant correlation as the postnatal age advances, with 
maximum correlation at 96 h (r=0.981), attributing it to the skin 
maturity and changes in albumin-bilirubin binding. Bland Altman 
plots also show that at 96 h, the agreement between TCB and TSB 
is excellent when compared to the values at earlier time intervals. 
Thus, there is a good correlation and excellent agreement of TSB 
and TCB at 96 h. This could also mean that the TCB can replace 
TSB as the time progresses. Once the babies are assigned a risk 
category according to the Bhutani’s TSB monogram [19], they 
could be followed up from72 h onward with a TCB value rather 
than a TSB value; thus, reducing the number of blood samples 
and unnecessary pricks for the newborn. The study contained only 
7.1% of late preterm babies, so the effect of TCB on postnatal age 
in preterm babies <34 weeks could not be assessed.
The usual peak of TSB occurs at age 72-120h, usually resolves 
by age 7-10 days, and the outcome is benign. Only approximately 
2-5% require readmission to a hospital for treatment [19]. In a 
country like ours, with less number of mothers delivering in a 
fully equipped hospital, and even lesser amount of these babies 
remaining in the hospital for more than 48 h, a follow-up criteria 
have to be established. In our hospital, the babies were advised 
discharge after 72 h of life. An hour-specific correlation can 
predict the risk of hyperbilirubinemia in babies; thus, preventing 
the future development of kernicterus.
The correlation of skin color with TCB has yet to be defined 
irrespective of race and place of origin. In USA, with the increasing 
number of migrants, there is a whole diversity of people with 
different skin colors and ethnic backgrounds. However, in India, 
where the population is fairly distributed into major skin color 
groups, only a small minority having the extremes of color (too 
light skinned or too dark skinned). Despite JM 103 and Bilicheck 
accounting for skin pigmentation in their design, the relationship 
between TCB and TSB is different in black infants. Color-coded 
scales were rarely used for the comparison, and more studies showed 
the imprecision of the bilirubinometry mostly based on race and 
ethnic backgrounds. The Fitzpatrick scales were used for this study; 
color code 3 has a higher correlation when compared to color code 
4. This was similar to the studies done that showed that darker skin 
tones have a poorer correlation [13,20]. Maisels et al. showed that 
JM 103 can overestimate TSB in black infants and the imprecision 
of Bilicheck increases as a degree of skin pigment increases [21].
The present study is the first of its kind to be conducted in the 
South Indian population; however, it has some limitations too. 
First, it is not a population-based study, and it represents the data 
of a single tertiary care hospital in South India. Second, most of the 
babies in the study belonged to Fitzpatrick skin color codes 3 and 
4 with very few babies falling into the other categories. Third, the 
timing of assessment at 24 h is too early for physiological jaundice 
peak. Another limitation is that the samples for all the designated 
time intervals are not the same; hence, it could have affected the 
validity of the data. The Bland Altman plots though showed great 
Table 2: TSB and TCB at designated times and their reliability
Time (n) 24 h (396) 48 h (196) 72 h (48) 96 h (22)
Mean TCB in mg/dl (SD) 7.4 (1.2) 11.6 (1.6) 13 (3.4) 13.2 (2.6)
Mean TSB in mg/dl (SD) 5.9 (1.1) 10.3 (1.6) 12.2 (3.3) 12.4 (2.8)
Mean difference of TCB and TSB 1.5 (0.7) 1.3 (0.6) 0.9 (0.7) 0.8 (0.6)
TSB: Total serum bilirubin, SD: Standard deviation
Table 3: Bland Altman analysis
TSB and TCB 
difference (hours)
Mean (SD) Mean+2SD Mean -2SD
TSB24 and TCB24 −1.54 (0.69) −0.16 −2.92
TSB48 and TCB48 −1.30 (0.62) −0.06 −2.54
TSB72 and TCB72 −0.89 (0.65) 0.41 −2.19
TSB96 and TCB96 −0.81 (0.60) 0.39 −2.01
TSB: Total serum bilirubin, SD: Standard deviation
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Figure 2: Correlations and Bland Altman plots of agreement of total serum bilirubin and TCBat 24 h
Figure 3: Correlations and Bland Altman plots of agreement of total serum bilirubin and TCB at 48 h
Figure 4: Correlations and Bland Altman plots of agreement of total serum bilirubin and TCB at 72 h
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agreement at 72 h and 96 h, they were done for a smaller sample 
size, and this could have also affected the validity and accuracy. 
Each institution should be aware of the unique relationship between 
its laboratory bilirubin values and TCB values. New policies should 
be made and implemented after understanding this relation. Further 
studies are needed to be done in a larger population with an equal 
number of subjects at each designated time spot.
CONCLUSION
This study finds that correlation of TCB and TSB increases as 
postnatal age advances. Designated TCB indices at different time 
spots could guide the pediatricians in safe discharge and targeted 
follow-up in at-risk babies. Transcutaneous bilirubinometry is 
most efficiently used as a screening test and values near or above 
age-specific risk cut off points should be confirmed with serum 
bilirubin values. Lighter skin color in babies showed a better 
correlation with TCB.
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